New Study Links Fosamax to Vision Problems Risk

According to a study published in April 2012 on the Canadian Medical Association Journal (CMAJ) first-time use of oral bisphosphonates (including Fosamax) is associated with greater risk for two inflammatory eye diseases, uveitis and scleritis. Fosamax, manufactured by Merck, was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. On June 29th, 2012 a South Carolina woman, Selma Wilson, filed a lawsuit in New Jersey District Court (case no. 3:2012cv04014) alleging she suffered femur fracture from her use of Fosamax. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fosamax severe adverse events. [http://www.attorneyone.com/fosamax-lawsuit/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fosamax: severe adverse events threat

Fosamax: severe adverse events threat

first-time use of oral bisphosphonates (including Fosamax) is associated with greater risk for two inflammatory eye diseases

San Diego, CA (PRWEB) September 14, 2012

The media spotlight is often a double-edged sword. No one knows this better than Selma Wilson and people who suffer from Fosamax Side Effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

A study published in April 2012 on the Canadian Medical Association Journal (CMAJ) reveals that first-time use of oral bisphosphonates (including Fosamax) is associated with greater risk for two inflammatory eye diseases, uveitis and scleritis. Fosamax, manufactured by Merck, was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. The retrospective cohort study, involving residents of British Columbia who had visited an ophthalmologist from 2000 to 2007, comprised 934,147 people, including 10,827 first-time users of bisphosphonates.

According to the article published in the Wall Street Journal on May 21st, 2012, Merck & Co. faces more than 3,100 product-liability lawsuits, including 1,200 alleging Fosamax caused jaw bones to decay in some patients, based on a recent filing it made with the Securities and Exchange Commission. On June 29th, 2012 a South Carolina woman, Selma Wilson, filed a lawsuit in New Jersey District Court (case no. 3:2012cv04014) alleging she suffered femur fracture from her use of Fosamax.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Fosamax, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fosamax remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In January 2011, the FDA issued a warning noting that bisphosphonates (incl. Fosamax) have been linked to atypical femur fractures.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/9/prweb9861841.htm.